Analysis
Hopscotch, a Chicago-based healthcare startup, raised $53 million in a Series D round led by Town Hall Ventures, with 8VC, aMoon Fund, Citi Impact Fund, Alumni Ventures, K2 HealthVentures and Autism Impact Fund also participating. The round funds Hopscotch's continued build-out of pediatric and behavioral health services delivered through a value-based care model.
Hopscotch's model ties reimbursement to patient outcomes rather than the traditional fee-for-service structure most pediatric and behavioral health providers still operate under -- a shift that has attracted specialized investors like K2 HealthVentures and Autism Impact Fund, both of which focus on outcomes-linked healthcare investments. The Chicago base puts Hopscotch outside the two coastal hubs (Boston/New York and the Bay Area) that dominate most healthcare-AI funding rounds this year.
“The Chicago base puts Hopscotch outside the two coastal hubs (Boston/New York and the Bay Area) that dominate most healthcare-AI funding rounds this year.”
The company operates in a segment adjacent to larger, better-known behavioral health players like Brightline and Cartwheel, both of which have raised significantly larger rounds targeting school-based and family mental health services. Hopscotch's focus on value-based reimbursement specifically -- rather than just digital access to care -- is the differentiator investors are underwriting, betting that outcomes-based contracts with payers scale better than pure telehealth access models as insurers push back on unmanaged utilization.
Series D at $53 million is a modest step-up rather than a headline megaround, reflecting a broader trend in healthcare funding this year: capital has concentrated in fewer, larger AI-infrastructure rounds while clinical-services startups raise smaller, more disciplined amounts tied to demonstrated outcomes data rather than growth-at-all-costs metrics. Hopscotch has not disclosed its post-money valuation or current patient volume, and the risk for any value-based care startup is that outcomes-linked payer contracts can take years to renegotiate favorably, which is a slower and less predictable revenue path than the subscription models most digital-health investors are used to underwriting, and a real reason this round is sized as a disciplined step-up rather than a growth-at-all-costs megaround.
